Cargando…

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides

The process of pre-mRNA splicing is a common and fundamental step in the expression of most human genes. Alternative splicing, whereby different splice motifs and sites are recognised in a developmental and/or tissue-specific manner, contributes to genetic plasticity and diversity of gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aung-Htut, May T., McIntosh, Craig S., Ham, Kristin A., Pitout, Ianthe L., Flynn, Loren L., Greer, Kane, Fletcher, Sue, Wilton, Steve D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834167/ https://www.ncbi.nlm.nih.gov/pubmed/31614438 http://dx.doi.org/10.3390/ijms20205030

Ejemplares similares

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021)

Antisense-mediated splice intervention to treat human disease: the odyssey continues
por: Pitout, Ianthe, et al.
Publicado: (2019)

Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
por: Flynn, Loren L., et al.
Publicado: (2018)

Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries
por: Zaw, Khine, et al.
Publicado: (2019)

Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in COL7A1
por: Ham, Kristin A., et al.
Publicado: (2020)

Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease
por: Aung-Htut, May Thandar, et al.
Publicado: (2020)

Single Stranded Fully Modified-Phosphorothioate Oligonucleotides can Induce Structured Nuclear Inclusions, Alter Nuclear Protein Localization and Disturb the Transcriptome In Vitro
por: Flynn, Loren L., et al.
Publicado: (2022)

Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies
por: Flynn, Loren L., et al.
Publicado: (2021)

Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
por: McIntosh, Craig S., et al.
Publicado: (2021)

Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
por: Cale, Jessica M., et al.
Publicado: (2021)

A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson’s Disease Arising from Parkin Mutations
por: Li, Dunhui, et al.
Publicado: (2020)

In Vitro Validation of Phosphorodiamidate Morpholino Oligomers
por: Aung-Htut, May T., et al.
Publicado: (2019)

Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA Processing
por: McIntosh, Craig S., et al.
Publicado: (2019)

Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations
por: McIntosh, Craig S., et al.
Publicado: (2021)

Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations
por: Cale, Jessica M., et al.
Publicado: (2023)

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
por: Mejzini, Rita, et al.
Publicado: (2019)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
por: Fragall, Clayton T, et al.
Publicado: (2011)

Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies
por: Li, Dunhui, et al.
Publicado: (2021)

Correction to: Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies
por: Li, Dunhui, et al.
Publicado: (2021)

Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells
por: Luo, Yue-Bei, et al.
Publicado: (2014)

Novel Mutations Found in Individuals with Adult-Onset Pompe Disease
por: Aung-Htut, May T., et al.
Publicado: (2020)

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries
por: Adams, Abbie M, et al.
Publicado: (2007)

The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
por: Martinovich, Kelly M., et al.
Publicado: (2018)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
por: Le, Bao T., et al.
Publicado: (2018)

Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy
por: Mitrpant, Chalermchai, et al.
Publicado: (2013)

Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of SMN2 in SMA Type I Fibroblasts
por: Toosaranont, Jarichad, et al.
Publicado: (2022)

Antisense suppression of donor splice site mutations in the dystrophin gene transcript
por: Fletcher, Sue, et al.
Publicado: (2013)

Induction of revertant fibres in the mdx mouse using antisense oligonucleotides
por: Fall, Abbie M, et al.
Publicado: (2006)

Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?
por: Li, Dunhui, et al.
Publicado: (2022)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
por: Wang, Zhenxun, et al.
Publicado: (2012)

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020)

The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
por: Ming, Xin, et al.
Publicado: (2013)

Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018)

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
por: Lim, Kian Huat, et al.
Publicado: (2020)

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation
por: Oren, Yifat S., et al.
Publicado: (2021)

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics
por: Larcher, Leon M., et al.
Publicado: (2023)

Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis
por: Michaels, Wren E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkj9em5gkbbfglas2k22pdo2u6